Literature DB >> 18691094

The epidemiology of sepsis.

Katherine E Hodgin1, Marc Moss.   

Abstract

Sepsis is a common and devastating syndrome that represents a significant healthcare burden worldwide. The average annual cost to care for patients with sepsis has been estimated to being $16.7 billion. Uniform definitions have been developed for the spectrum of sepsis syndrome, including the systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock. SIRS describes the clinical manifestations derived from an acute yet nonspecific illness, whereas an infectious etiology is required for the diagnosis of sepsis. As sepsis progresses, organ system dysfunction becomes apparent (severe sepsis) with the final development of fluid refractory cardiovascular dysfunction (septic shock). Pulmonary, gastrointestinal, genitourinary, and primary bloodstream infections account for the majority of infectious sources in septic patients. Since 1987, gram positive bacteria have become the most common organisms responsible for the development of sepsis. Several risk factors for the development of sepsis have been identified including male sex, race, age, comorbid medical conditions, alcohol abuse, and a lower socioeconomic status. Seasonal variations also exist, with sepsis being more common in the winter months. Fortunately, the case fatality rates for both sepsis and severe sepsis have diminished over the last two decades. However, patients who survive their episode of sepsis continue to have increased morbidity and mortality up to five years after their initial illness.

Entities:  

Mesh:

Year:  2008        PMID: 18691094     DOI: 10.2174/138161208784980590

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  19 in total

Review 1.  The Economic and Humanistic Burden of Severe Sepsis.

Authors:  Bogdan Tiru; Ernest K DiNino; Abigail Orenstein; Patrick T Mailloux; Adam Pesaturo; Abhinav Gupta; William T McGee
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

2.  Accentuate the (Gram) positive.

Authors:  Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2010-02-20       Impact factor: 4.599

3.  Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis.

Authors:  Orit Barrett; Ella Abramovich; Jacob Dreiher; Victor Novack; Mahmoud Abu-Shakra
Journal:  Rheumatol Int       Date:  2017-03-12       Impact factor: 2.631

Review 4.  Sepsis: from pattern to mechanism and back.

Authors:  Gary An; Rami A Namas; Yoram Vodovotz
Journal:  Crit Rev Biomed Eng       Date:  2012

5.  Patient and hospital-level characteristics associated with the use of do-not-resuscitate orders in patients hospitalized for sepsis.

Authors:  Dong W Chang; Eric P Brass
Journal:  J Gen Intern Med       Date:  2014-06-14       Impact factor: 5.128

6.  Clinical Epidemiology of SIRS and Sepsis in Newly Admitted Children.

Authors:  Sheetal Ganjoo; Kaisar Ahmad; Umar Amin Qureshi; Zahed Hussain Mir
Journal:  Indian J Pediatr       Date:  2014-11-29       Impact factor: 1.967

7.  Translational systems biology of inflammation: potential applications to personalized medicine.

Authors:  Qi Mi; Nicole Yee-Key Li; Cordelia Ziraldo; Ali Ghuma; Maxim Mikheev; Robert Squires; David O Okonkwo; Katherine Verdolini-Abbott; Gregory Constantine; Gary An; Yoram Vodovotz
Journal:  Per Med       Date:  2010-09-01       Impact factor: 2.512

8.  Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides.

Authors:  Hemamali J Warshakoon; Mark R Burns; Sunil A David
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

Review 9.  Vitamin D in sepsis: from basic science to clinical impact.

Authors:  Jordan A Kempker; Vin Tangpricha; Thomas R Ziegler; Greg S Martin
Journal:  Crit Care       Date:  2012-07-19       Impact factor: 9.097

10.  Vitamin D and sepsis: An emerging relationship.

Authors:  Jordan A Kempker; Jenny E Han; Vin Tangpricha; Thomas R Ziegler; Greg S Martin
Journal:  Dermatoendocrinol       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.